5. A 7-year-old boy accidentally inhales a small peanut, which lodges in
one of his bronchi. A chest x-ray reveals the mediastinum to be shifted
toward the side of the obstruction. Which of the following pulmonary
abnormalities is most likely present in this boy?
a. Absorptive atelectasis
b. Compression atelectasis
c. Contraction atelectasis
d. Patchy atelectasis
e. Hyaline membrane disease
25. Histology
• Alveolar space in the affected area
– are small with thick interalveolar septa.
– Contain proteinaceous fluid with scattered epithelial
squames & meconium.
• Scattered aerated space
26. Neonatal respiratory distress
syndrome
• Hyaline membrane disease
• Characterised by hyaline membrane formation
• Begins with dyspnoea a few after birth with
tachypnoea, hypoxia and cyanosis and in severe
case death occurs in few hours.
27. • More common in LBW babies
• Etiology.
Preterm baby
Infants born to diabetic mothers
Delivery by caesarean section without
preceding labour
Excessive sedation
Birth asphyxia
Male preponderance
39. Microvascular injury
• Injury to endothelial or epithelial cells
• Leakage of fluids and proteins into the interstitial
space → alveoli
• Localized: symptoms of infection
• Diffuse: ARDS
41. ARDS
• Clinical syndrome caused by diffuse alveolar
capillary damage
Clinically,
• Severe life threatening respiratory insufficiency
of rapid onset
• Cyanosis
• Severe arterial hypoxemia refractory to o2
• Progress to multisystem organ failure
44. Acute alveolar injury
Release of cytokines
By Macrophages
(IL1, 8, TNF)
By Activated neutrophils
(Protease, leukotrienes,
PAF, Oxidases)
Local tissue damage, intra alveolar edema loss of diffusion capacity and
damage to type II alveolar pneumocytes Surfactant inactivation
HYALINE MEMBRANE
STIFF LUNG
45. Clinical course
• Previously hospitalized pts develop tachypnea
and dyspnea
• Increasing cyanosis and hypoxemia
• Unresponsive to oxygen therapy
• Respiratory acidosis develops
47. Morphology - Acute stage:
• Heavy, firm, red and boggy
• Congestion, intra-alveolar edema, inflammation
and fibrin deposition
• Alveolar walls lined by waxy hyaline
membranes
• Fibrin rich edema fluid mixed with cytoplasmic
and lipid remnants of necrotic epithelial cells
48. Organizing stage
• Type II pneumocytes proliferate
• Organization of the exudate intra alveolar
fibrosis
• Thickening of alveolar septa
• Proliferation of interstitial cells and deposition of
collagen
• Fatal cases superimposed bronchopneumonia.
49. The blue arrows point to intralveolar macrophages and type II pneumocytes.
• The green arrow identifies brightly eosinophilic hyaline membranes.
50. • The blue arrows point to the type II pneumocytes which are very prominent;
their nuclei protruding into the alveolar space.
• The arrows highlight the thickened septum.
• The septum contains excess collagen, fibroblasts, and lymphocytes.
• Hyaline membranes are not present.
51.
52. A 7-year-old boy accidentally inhales a small peanut, which
lodges in one of his bronchi. A chest x-ray reveals the
mediastinum to be shifted toward the side of the
obstruction. Which of the following pulmonary
abnormalities is most likely present in this boy?
• a. Absorptive atelectasis
• b. Compression atelectasis
• c. Contraction atelectasis
• d. Patchy atelectasis
• e. Hyaline membrane disease
Hinweis der Redaktion
Surfactants are compounds that lower the surface tension (or interfacial tension) between two liquids or between a liquid and a solid
Babies are considered premature if they are born before 37 weeks gestation. Fetuses begin to produce surfactant betweenweeks 24 and 28. By about 35 weeks, most babies have enough naturally produced surfactant to keep the alveoli fromcollapsing. Babies born before 35 weeks, especially those born very prematurely (before 30 weeks), are likely to needsurfactant replacement therapy. Over half the babies born before 28 weeks gestation need this treatment, while about one-third born between 32 and 36 weeks need supplemental surfactant.
Composition[edit]
~40% dipalmitoylphosphatidylcholine (DPPC);
∼40% other phospholipids (PC);
~5% surfactant-associated proteins (SP-A, B, C and D);
Cholesterol (neutral lipids);
Traces of other substances.